Privia Health Group (NASDAQ:PRVA) Coverage Initiated at Needham & Company LLC

Needham & Company LLC initiated coverage on shares of Privia Health Group (NASDAQ:PRVA) in a research note issued on Friday, MarketBeat reports. The firm set a “buy” rating and a $25.00 price target on the stock. Needham & Company LLC’s price target would suggest a potential upside of 19.45% from the stock’s previous close.

A number of other analysts also recently commented on the company. Truist Financial raised their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. JPMorgan Chase & Co. lifted their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. Macquarie initiated coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price objective for the company. Stephens reiterated an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a research report on Thursday, January 2nd. Finally, Barclays increased their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $24.88.

Privia Health Group Stock Performance

Shares of PRVA opened at $20.93 on Friday. The company has a 50-day simple moving average of $20.90 and a 200-day simple moving average of $19.40. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $23.78. The firm has a market capitalization of $2.51 billion, a P/E ratio of 209.32, a P/E/G ratio of 5.45 and a beta of 0.85.

Institutional Investors Weigh In On Privia Health Group

A number of institutional investors and hedge funds have recently made changes to their positions in the company. FMR LLC increased its position in Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after purchasing an additional 271,645 shares during the period. Geode Capital Management LLC grew its position in shares of Privia Health Group by 1.0% during the 3rd quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock worth $43,986,000 after buying an additional 23,178 shares during the period. Franklin Resources Inc. grew its position in shares of Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after buying an additional 28,480 shares during the period. Millennium Management LLC raised its stake in shares of Privia Health Group by 2,994.2% during the second quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock worth $19,788,000 after buying an additional 1,101,730 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Privia Health Group by 18.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock valued at $19,441,000 after buying an additional 173,934 shares during the period. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.